Matrix metalloproteinases and tumor necrosis factor α in glaucomatous optic nerve head

Archives of Ophthalmology

Volumn 118, Issue 5, 2000, Pages 666-673

  Yan, Xiaoming ^a   Tezel, Gülgün ^b   Wax, Martin B ^b   Edward, Deepak P ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLAUCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0034128172     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.5.666     Document Type: Article

References (44)

1. Wax MB, Tezel G, Edward DP. Clinical and histopathological findings of a patient with normal-pressure glaucoma. Arch Ophthalmol. 1998;116:993-1001.
2. Morrison JC, Dorman-Pease ME, Dunkelberger GR, Quigley HA. Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma. Arch Ophthalmol. 1990;108:1020-1024
3. Hernandez MR, Andrzejewska WM, Neufeld AH. Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma. Am J Ophthalmol. 1990;109:180-188.
4. Quigley HA, Dorman-Pease ME, Brown AE. Quantitative study of collagen and elastin of the optic nerve head and sclera in human and experimental monkey glaucoma. Curr Eye Res. 1991;10:877-888.
5. Hernandez MR. Ultrastructural immunocytochemical analysis of elastin in the human lamina cribrosa: changes in elastic fibers in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1992;33:2891-2903.
6. Varela HJ, Hernandez MR. Astrocyte responses in human optic nerve head with primary open-angle glaucoma J Glaucoma. 1997;6:303-313.
7. Minckler DS, Spaeth GL. Optic nerve damage in glaucoma. Surv Ophthalmol. 1981; 26:128-148
8. Quigley HA, Hohman RM, Addicks EM, Massof RW, Green WR. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol. 1983;95:673-691.
9. Okada Y, Gonoji Y, Nakanishi I, Nagase H, Hayakawa T. Immunohistochemical demonstration of collagenases and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synoviurn. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990:59:305-312.
10. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991;5:2145-2154.
11. Backstrom JR, Miller CA, Tokes ZA. Characterization of neural proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. J Neurochem. 1992;58: 983-992.
12. Giraudon P, Buart S, Bernard A, Thomasset N, Belin MF. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-1). Prog Neurobiol. 1996; 49:169-184.
13. Rosenberg GA, Navratil M, Barone F, Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metabol. 1996;16: 360-366.
14. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997;20:570-577.
15. Gottschall PE, Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem. 1995;64:1513-1520.
16. Gattschall PE, Deb S. Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons. Neuroimmunomodulation. 1996;3:69-75.
17. Migita K, Eguchi K, Kawabe Y, et al. TNF-α-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology. 1996;89:553-557.
18. Chandler S, Miller KM, Clements JM, et al. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol. 1997;72: 155-161.
19. Apodaca G. Rutka JT, Bouhana K, et al. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res. 1990; 50:2322-2329.
20. Eddleston M, Mucke L. Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience. 1993;54:15-36.
21. Romanic AM, Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 1994;4:145-156.
22. Nakagawa T, Kubota T, Kabuto M, et al. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg. 1994;81:69-77.
23. Maeda A, Sobel RA. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol. 1996;55:300-309.
24. Johnson EC, Deppmeier LMH, Varner AC, Morrison JC. Matrix metalloproteinases and TIMP-1 in the primate optic nerve head and retina. Presented at: the Association for Research in Vision and Ophthalmology Annual Meeting; May 5, 1993; Sarasota, Fla.
25. Emi K, Sawaguchi S, Yue B, Hara H. Fukuchi T, Iwata K. Increased levels of matrix metalloproteinase in the optic nerve head of monkey eyes with laser-induced glaucoma. Presented at: the Association for Research in Vision and Ophthalmology Annual Meeting; May 6, 1993; Sarasota, Fla.
26. Sawaguchi S, Fukuchi T, Hanyu J, et al. Matrix melalloproteinase were over-expressed in the optic nerve heads of experimental primate glaucoma. Presented at: the Association for Research in Vision and Ophthalmology Annual Meeting; May 12, 1998; Fort Lauderdale, Fla.
27. Raff MC. Glial cell diversification in the rat optic nerve. Science. 1989;243:1450-1455.
28. Radany EH, Brenner M, Besnard F, Bigornia V, Bishop JM, Deschepper CF. Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes. Proc Natl Acad Sci U S A. 1992;89:6467-6471.
29. Ye H, Hernandez MR. Heterogeneity of astrocytes in human optic nerve head. J Comp Neurol. 1995;362:441-452.
30. Hernandez MR, Pena JD. The optic nerve head changes in glaucomatous optic neuropathy. Arch Ophthalmol. 1997;115:389-395.
31. Nordstrom LA, Lochner J, Yeung W, Ciment G. The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae. Mol Cell Neurosci. 1995;6:56-68.
32. Schwartz M, Cohen A, Stein-Izsak ,. Belkin M. Dichotomy of the glial cell response to axonal injury and regeneration. FASEB J. 1989;3:2371-2378.
33. Muir D. Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res. 1994;210: 243-252.
34. Hernandez MR, Igoe F, Neufeld AH. Extracellular matrix of the human optic nerve head. Am J Ophthalmol. 1986;102:139-148.
35. Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, Stetler-Stevenson WG. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res. 1992;576:203-207.
36. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-α expression in ischemic neurons. Stroke. 1994;25:1481-1488.
37. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-α: a mediator of focal ischemic brain injury. Stroke. 1997;28:1233-1244.
38. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 1995;81:495-504.
39. Lin X, Kashima Y, Khan M, Heller KB, Gu X, Sadun AA. An immunohistochemical study of TNF-α in optic nerves from AIDS patients. Curr Eye Res. 1997;16: 1064-1068.
40. Romero Ll, Tatro JB, Field JA, Reichlin S. Roles of IL-1 and TNF-alpha in the endotoxin-induced activation of nitric oxide synthase in cultured rat brain cells. Am J Physiol. 1996;270:R326-R332.
41. Goureau O, Amiot F, Dautry F, Courtois Y. Control of nitric oxide production by endogenous TNF-alpha in mouse retinal pigmented epithelial and Muller glial cells. Biochem Biophys Res Commun. 1997;240:132-135.
42. Heneka MT, Loschmann PA, Gleichmann M, et al. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor alpha/lipopolysaccharide. J Neurochem. 1998; 71:88-94.
43. Neufeld AH. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma. Surv Ophthalmol. 1999;43(suppl 1):S129-S135.
44. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999;96:9944-9948.